High caffeine levels associated with weight loss and type 2 diabetes risk: BMJ

Published Date: 17 Mar 2023

UK: A recent study published in BMJ Medicine found that more caffeine in the blood can reduce the risk of type 2 diabetes and obesity. more...

Read Full News

Latest News

600,000 Seniors Have Signed Up for Obesity Drugs Under New Medicare Program

U.S. Centers for ⁠Medicare and Medicaid Services Administrator ⁠Dr. Mehmet Oz said ⁠on Monday ‌that 600,000 seniors have signed up to receive GLP-1 weight ‌loss medications...

Hims & Hers Offers GLP-1s, Men's Health Treatments in Australia

Telehealth company Hims & Hers has begun offering GLP-1 weight-loss drugs and other treatments ⁠to men in Australia as it continues to expand its international business.

Time-Restricted Eating Helps Sustain Weight Loss

New research shows an 8-hour eating window can help sustain weight loss for a year. Meal timing, alongside diet quality and exercise may be a useful, personalized tool.

GLP-1 Weight Loss Drugs Effective Even At Low Starter Doses

People taking popular GLP-1 obesity drugs who remain on low starter doses will lose some weight but may still experience side effects, although significantly less nausea...

Novo Nordisk Launches Wegovy Weight-Loss Pill in Germany

Novo Nordisk has launched its Wegovy pill in Germany, a spokesperson for the Danish drugmaker said on Tuesday.

Thyroid Shifts in Midlife Women? Blame Aging, Not Menopause

Thyroid problems in midlife women may have less to do with menopause than doctors think, and more to do with simply getting older, a new study suggests.

Todays Updates

Can 80 Gy Radiation Boost Survival in Prostate Cancer?

A modest increase in radiation dose improves progression-free survival over 10 years among men with high-risk prostate cancer — but the overall survival benefits found in a French trial are uncertain.

Todays Updates

Can 80 Gy Radiation Boost Survival in Prostate Cancer?

A modest increase in radiation dose improves progression-free survival over 10 years among men with high-risk prostate cancer — but the overall survival benefits found in a French trial are uncertain.

Latest News

U.S. Centers for ⁠Medicare and Medicaid Services Administrator ⁠Dr. Mehmet Oz said ⁠on Monday ‌that 600,000 seniors have signed up to receive GLP-1 weight ‌loss medications...

Telehealth company Hims & Hers has begun offering GLP-1 weight-loss drugs and other treatments ⁠to men in Australia as it continues to expand its international business.

New research shows an 8-hour eating window can help sustain weight loss for a year. Meal timing, alongside diet quality and exercise may be a useful, personalized tool.

People taking popular GLP-1 obesity drugs who remain on low starter doses will lose some weight but may still experience side effects, although significantly less nausea...

Novo Nordisk has launched its Wegovy pill in Germany, a spokesperson for the Danish drugmaker said on Tuesday.

Thyroid problems in midlife women may have less to do with menopause than doctors think, and more to do with simply getting older, a new study suggests.

News All Time

Traditional Chinese Medicines Plus Metformin Improve A1c

In a phase 3 trial, adding a combo of two traditional Chinese meds to metformin reduced A1c and improved lipid measure in patients with T2D whose glycemic control was inadequate with metformin alone.

T2D Linked to Brain Thinning in Older Adults

Older adults with type 2 diabetes have faster cortical thinning in several brain regions and greater decline in processing speed, a study finds.

Surgery Underused in Primary Hyperparathyroidism Care

Two thirds of patients with primary hyperparathyroidism have or develop end-organ damage, but only 20% undergo parathyroidectomy, a national cohort study shows.

The Hidden Cost of Daily Steroids in Duchenne Dystrophy

Boys with Duchenne muscular dystrophy on daily corticosteroids maintained walking ability 4 years longer than those on intermittent treatment, but at what cost to their bone health and growth?

More Water, More Food; More Spice, Less Food

Two studies challenge conventional weight-loss advice.

1 in 4 Regain Significant Weight After Bariatric Surgery

Most patients maintain their weight loss for years after bariatric surgery, but about 1 in 4 regain significant weight, with inappropriate eating habits linked to weight regain.

The Medicare GLP-1 Discount Has One Big Catch

About 1 in 5 American adults have taken a GLP-1 medication, and most of them, including those with health insurance, say the drugs are difficult to afford.

Pancreatic Cancer Referral Rate Low in Diabetes, Weight Loss

Among adults aged 60 years or older with new-onset diabetes and unexplained weight loss, referrals and abdominal imaging for suspected pancreatic cancer appear low in primary care.

Remote Program Aids Obesity Medication Access

Pharmacists and navigators can expand obesity drug access without doctor visits — but drug shortages, insurance hurdles, and paperwork, not patient willingness, are the real bottlenecks to scale.

India Wanted Red Flags on Chip Packets and Soda. Big Food Fought Back

A can of Fanta sold in London has 63 calories. Buy the same brand in India, and it contains three times as much sugar. It also includes artificial dye, whose presence in...

Diabetes Prevention Starts Earlier Than Thought

An expert panel says diabetes prevention should start long before hyperglycemia, with risk shaped across pregnancy, childhood, and adulthood.

FDA OKs Gene Therapy for Glycogen Storage Disease Type Ia

The FDA grants accelerated approval for the innovative, one-time gene therapy Genglycos to treat the rare disease GSDIa in children aged 8 years and older and adults.

Does Telehealth-Only GLP-1 Care Fall Short?

Many vital tests and evaluations a patient needs before and after starting GLP-1s can’t be done over the computer.

Partner Weight Loss Increases When Included in Program

A behavioral weight-loss program aimed at one partner can produce meaningful, lasting weight loss in the other — despite never asking them to change their own habits.

Is There a ‘Best’ GLP-1 Injection Site?

Experts say any of the three approved subcutaneous injection sites for GLP-1s will work, but users, and some social media influencers, have strong opinions about which is best.

Fatigue, Brain Fog Persist in Women With Prolactinoma

Even with prolactin levels under control, many women with a prolactinoma still battle fatigue and concentration problems, a new Dutch cohort study reveals.

Recommended News For You

Study confirms safety and efficacy of higher-dose-per-day radiation for early-stage prostate cancer

Poor agreement between diagnostic tests for breast cancer-related lymphedema

Researchers discover that children who survive cancer have socioeconomic challenges.

Research exposes far-reaching toll of financial hardship on patients with cancer

The hidden costs of cancer for young survivors are derailing their financial futures

In advanced endometrial cancer, immunocheckpoint inhibitor-chemotherapy combination improves overall survival.

Chemicals in Sewage Sludge Fertilizer Pose Cancer Risk, EPA Says

Recommended Articles For You

Advanced Practices in Hematology in Daily Practice 

Refining AML Survival: Prognostic Factors, Therapies, and Stem Cell Strategies Reviewed 

Chronic Cancer Survivorship: Managing Long-Term Outcomes with Precision Care 

Unlocking the Unknown: A Comprehensive Guide to Stage 4 Vulvar Cancer 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

The Clues Hidden in Failed Prostate Cancer Trials

2.

Updates from the 2022 WHO classification of kidney epithelial tumors

3.

Immunotherapy and targeted radiation shrink liver tumors, enabling surgery

4.

We Don't Always Know What's 'Best' for Our Patients

5.

Conditional EU Nod for Weekly Pill in Pediatric Glioma

1.

AI on the Front Lines: Revolutionizing Breast Cancer Detection with Artificial Intelligence

2.

Gynecologic Oncology: Advances, Education, and Clinical Excellence

3.

Integrating Immunotherapy and Staging Guidelines in Lung Cancer Treatment

4.

Contemporary Frameworks in Oncology Across Clinical Settings

5.

Unlocking the Immune Arsenal: A Revolution in Cancer Treatment

1.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

2.

International Cancer Conference

3.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part II

2.

Oropharyngeal Cancer in Relation to HPV Status

3.

Navigating the Complexities of Ph Negative ALL - Part XV

4.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part V

5.

Efficient Management of First line ALK-rearranged NSCLC - Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot